Edwards heart valve system good as surgery at 3 years-trial
SAN FRANCISCO (Reuters) - Patients who received the original version of Edwards Lifesciences Corp's non-invasive heart valve replacement system had a nearly identical death rate after three years as those who had open-heart surgery, with no increased risk of stroke, according to results from a clinical trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cardiology | Clinical Trials | Health | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Stroke